The purpose of this study is to identify the best way to prevent bone loss in the first years
after menopause. The HOPS study will compare bone loss at 12 months in women: 1) who take
calcium and vitamin D only; 2) who take calcium and vitamin D plus the medication
"risedronate"; or 3) who take calcium and vitamin D plus participate in bone-loading
exercises. Our central hypothesis is that improvements in bone health will be greater in
women randomized to bone-loading exercises with calcium and vitamin D compared to women who
take calcium and vitamin D only or women who take calcium and vitamin D plus risedronate.
Phase:
Phase 3
Details
Lead Sponsor:
Nancy L. Waltman, BSN MSN PhD
Collaborators:
Creighton University Medical Center University of Nebraska